Skip to content

APPLIED GENETIC TECHNOLOGIES CORP

CIK 0001273636

← back to feed
Revenue (TTM)
$0
−35.0% YoY Q1 Nov 2022
Net Income (TTM)
−$68.97M
−28.6% YoY Q1 Nov 2022
EPS Diluted (TTM)
−$1.46
−9.1% YoY Q1 Nov 2022
Gross Margin
—
Q1 Nov 2022
Operating Margin
—
Q1 Nov 2022
Net Margin
—
Q1 Nov 2022
Free Cash Flow (TTM)
−$57.23M
Q1 Nov 2022
Cash
$34.24M
Q1 Nov 2022
Total Debt
$16.34M
Q1 Nov 2022
Shares Outstanding
67.63M sh
Q1 Nov 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings